MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$18,317K
Decrease (increase) in
accounts...
-$6,408K
Short-term deposit
withdrawal
$10,000K
Exercise of warrants and
options
$150K
Increase (decrease) in
accounts payable and...
$820K
Share-based compensation
$532K
Depreciation
$404K
Financial (income)
expenses, net
-$158K
Changes in deferred
income tax asset
$71K
Changes in operating
lease right of use...
-$55K
Changes in accrued
liability for employee...
$5K
Net cash provided by
(used in) operating...
$22,025K
Net cash provided by
(used in) investing...
$4,223K
Net cash provided by
financing activities
$150K
Canceled cashflow
$4,745K
Canceled cashflow
$5,777K
Net increase
(decrease) in cash and cash...
$26,321K
Canceled cashflow
$77K
Decrease (increase) in
inventories
$4,745K
Investment in bank deposits
$5,000K
Purchase of property and
equipment
$761K
Increase in restricted
deposit
$9K
Amounts funded in
respect of employee...
$7K
Effect of exchange rate
changes on cash and cash...
-$77K
Back
Back
Cash Flow
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX)
source: myfinsight.com